DMAC EPS Estimates - DiaMedica Therapeutics Inc. logo

DMAC EPS Estimates

DiaMedica Therapeutics Inc.

$8.59
+$0.21(+2.51%)
47
Overall
40
Value
66
Tech
36
Quality
How is this score calculated?
Market Cap
$463.49M
Volume
207.42K
52W Range
$5.25 - $11.00
Target Price
$15.50

DMAC EPS estimates: the consensus estimate for DiaMedica Therapeutics Inc.'s current fiscal year is -$0.84 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.

DMAC EPS Estimates

EPS estimate, current quarter
$-0.22
EPS estimate, current year
$-0.84
EPS estimate, next year
$-0.81
EPS growth, 3-year
-10.42%
DMAC reported EPS by year
Fiscal yearEPS
2025$-0.70
2024$-0.60
2023$-0.60
2022$-0.52
2021$-0.65
ABCD
1SymbolPriceChangeVol
2DMAC$8.59+2.5%207.42K
3
4
5
6

Get DiaMedica Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.